Estimating the risk of gestational diabetes mellitus based on the 2013 WHO criteria: a prediction model based on clinical and biochemical variables in early pregnancy.


Journal

Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 23 10 2019
accepted: 16 12 2019
pubmed: 10 1 2020
medline: 21 8 2020
entrez: 10 1 2020
Statut: ppublish

Résumé

We aimed to develop a prediction model based on clinical and biochemical variables for gestational diabetes mellitus (GDM) based on the 2013 World Health Organization (WHO) criteria. A total of 1843 women from a Belgian multi-centric prospective cohort study underwent universal screening for GDM. Using multivariable logistic regression analysis, a model to predict GDM was developed based on variables from early pregnancy. The performance of the model was assessed by receiver-operating characteristic (AUC) analysis. To account for over-optimism, an eightfold cross-validation was performed. The accuracy was compared with two validated models (van Leeuwen and Teede). A history with a first degree relative with diabetes, a history of smoking before pregnancy, a history of GDM, Asian origin, age, height and BMI were independent predictors for GDM with an AUC of 0.72 [95% confidence interval (CI) 0.69-0.76)]; after cross-validation, the AUC was 0.68 (95% CI 0.64-0.72). Adding biochemical variables, a history of a first degree relative with diabetes, a history of GDM, non-Caucasian origin, age, height, weight, fasting plasma glucose, triglycerides and HbA A model based on easy to use variables in early pregnancy has a moderate accuracy to predict GDM based on the 2013 WHO criteria.

Identifiants

pubmed: 31915927
doi: 10.1007/s00592-019-01469-5
pii: 10.1007/s00592-019-01469-5
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0
Glycated Hemoglobin A 0
Triglycerides 0
hemoglobin A1c protein, human 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

661-671

Références

American Diabetes A (2019) 14. Management of diabetes in pregnancy: standards of medical care in diabetes-2019. Diabetes Care 42(Suppl 1):S165–S172. https://doi.org/10.2337/dc19-S014
doi: 10.2337/dc19-S014
Crowther CA, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New Engl J Med 352(24):2477–2486. https://doi.org/10.1056/NEJMoa042973
doi: 10.1056/NEJMoa042973 pubmed: 15951574
Landon MB, Spong CY, Thom E et al (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. New Engl J Med 361(14):1339–1348. https://doi.org/10.1056/NEJMoa0902430
doi: 10.1056/NEJMoa0902430 pubmed: 19797280
Song C, Lyu Y, Li C et al (2018) Long-term risk of diabetes in women at varying durations after gestational diabetes: a systematic review and meta-analysis with more than 2 million women. Obes Rev 19(3):421–429. https://doi.org/10.1111/obr.12645
doi: 10.1111/obr.12645 pubmed: 29266655
Xu Y, Shen S, Sun L, Yang H, Jin B, Cao X (2014) Metabolic syndrome risk after gestational diabetes: a systematic review and meta-analysis. PLoS ONE 9(1):e87863. https://doi.org/10.1371/journal.pone.0087863
doi: 10.1371/journal.pone.0087863 pubmed: 24498216 pmcid: 3909287
Kramer CK, Campbell S, Retnakaran R (2019) Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia 62(6):905–914. https://doi.org/10.1007/s00125-019-4840-2
doi: 10.1007/s00125-019-4840-2 pubmed: 30843102
Benhalima K, Lens K, Bosteels J, Chantal M (2019) The risk for glucose intolerance after gestational diabetes mellitus since the introduction of the IADPSG criteria: a systematic review and meta-analysis. J Clin Med. https://doi.org/10.3390/jcm8091431
doi: 10.3390/jcm8091431 pubmed: 31510081 pmcid: 6780861
International Association of D, Pregnancy Study Groups Consensus P, Metzger BE et al (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3):676–682. https://doi.org/10.2337/dc09-1848
doi: 10.2337/dc09-1848
(2014) Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract 103(3):341–363
Benhalima K, Mathieu C, Van Assche A et al (2016) Survey by the European Board and College of Obstetrics and Gynaecology on screening for gestational diabetes in Europe. Eur J Obstet Gynecol Reprod Biol 201:197–202. https://doi.org/10.1016/j.ejogrb.2016.04.003
doi: 10.1016/j.ejogrb.2016.04.003 pubmed: 27129745
Farrar D, Simmonds M, Bryant M et al (2017) Risk factor screening to identify women requiring oral glucose tolerance testing to diagnose gestational diabetes: a systematic review and meta-analysis and analysis of two pregnancy cohorts. PLoS ONE 12(4):e0175288. https://doi.org/10.1371/journal.pone.0175288
doi: 10.1371/journal.pone.0175288 pubmed: 28384264 pmcid: 5383279
Lamain-de Ruiter M, Kwee A, Naaktgeboren CA et al (2016) External validation of prognostic models to predict risk of gestational diabetes mellitus in one Dutch cohort: prospective multicentre cohort study. BMJ 354:i4338. https://doi.org/10.1136/bmj.i4338
doi: 10.1136/bmj.i4338 pubmed: 27576867
van Leeuwen M, Opmeer BC, Zweers EJ et al (2010) Estimating the risk of gestational diabetes mellitus: a clinical prediction model based on patient characteristics and medical history. BJOG 117(1):69–75. https://doi.org/10.1111/j.1471-0528.2009.02425.x
doi: 10.1111/j.1471-0528.2009.02425.x pubmed: 20002371
Teede HJ, Harrison CL, Teh WT, Paul E, Allan CA (2011) Gestational diabetes: development of an early risk prediction tool to facilitate opportunities for prevention. Aust N Z J Obstet Gynaecol 51(6):499–504. https://doi.org/10.1111/j.1479-828X.2011.01356.x
doi: 10.1111/j.1479-828X.2011.01356.x pubmed: 21951203
Schoenaker D, Vergouwe Y, Soedamah-Muthu SS, Callaway LK, Mishra GD (2018) Preconception risk of gestational diabetes: development of a prediction model in nulliparous Australian women. Diabetes Res Clin Pract 146:48–57. https://doi.org/10.1016/j.diabres.2018.09.021
doi: 10.1016/j.diabres.2018.09.021 pubmed: 30296462
Sweeting AN, Appelblom H, Ross GP et al (2017) First trimester prediction of gestational diabetes mellitus: a clinical model based on maternal demographic parameters. Diabetes Res Clin Pract 127:44–50. https://doi.org/10.1016/j.diabres.2017.02.036
doi: 10.1016/j.diabres.2017.02.036 pubmed: 28319801
Nanda S, Savvidou M, Syngelaki A, Akolekar R, Nicolaides KH (2011) Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn 31(2):135–141. https://doi.org/10.1002/pd.2636
doi: 10.1002/pd.2636 pubmed: 21268030
Huvinen E, Eriksson JG, Koivusalo SB et al (2018) Heterogeneity of gestational diabetes (GDM) and long-term risk of diabetes and metabolic syndrome: findings from the RADIEL study follow-up. Acta Diabetol 55(5):493–501. https://doi.org/10.1007/s00592-018-1118-y
doi: 10.1007/s00592-018-1118-y pubmed: 29460080
Benhalima K, Van Crombrugge P, Verhaeghe J et al (2014) The Belgian Diabetes in Pregnancy Study (BEDIP-N), a multi-centric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design. BMC Pregnancy Childbirth 14:226. https://doi.org/10.1186/1471-2393-14-226
doi: 10.1186/1471-2393-14-226 pubmed: 25015413 pmcid: 4227277
Benhalima K, Van Crombrugge P, Moyson C et al (2018) The sensitivity and specificity of the glucose challenge test in a universal two-step screening strategy for gestational diabetes mellitus using the 2013 World Health Organization criteria. Diabetes Care 41(7):e111–e112. https://doi.org/10.2337/dc18-0556
doi: 10.2337/dc18-0556 pubmed: 29748432
Benhalima K, Van Crombrugge P, Moyson C et al (2018) A modified two-step screening strategy for gestational diabetes mellitus based on the 2013 WHO criteria by combining the glucose challenge test and clinical risk factors. J Clin Med. https://doi.org/10.3390/jcm7100351
doi: 10.3390/jcm7100351 pubmed: 30322138 pmcid: 6210855
Benhalima K, Van Crombrugge P, Moyson C et al (2019) Prediction of glucose intolerance in early postpartum in women with gestational diabetes mellitus based on the 2013 WHO criteria. J Clin Med. https://doi.org/10.3390/jcm8030383
doi: 10.3390/jcm8030383 pubmed: 31510081 pmcid: 6780861
Benhalima K, Van Crombrugge P, Moyson C et al (2019) Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria. Eur J Endocrinol Eur Fed Endocr Soc 180(6):353–363. https://doi.org/10.1530/EJE-19-0117
doi: 10.1530/EJE-19-0117
Benhalima K, Van Crombrugge P, Moyson C et al (2019) Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance. Diabetologia 62(11):2118–2128. https://doi.org/10.1007/s00125-019-4961-7
doi: 10.1007/s00125-019-4961-7 pubmed: 31338546
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419
doi: 10.1007/BF00280883 pubmed: 3899825
Duran A, Martin P, Runkle I et al (2010) Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes 2(3):203–211. https://doi.org/10.1111/j.1753-0407.2010.00081.x
doi: 10.1111/j.1753-0407.2010.00081.x pubmed: 20923485
Poston L, Bell R, Croker H et al (2015) Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. Lancet Diabetes Endocrinol 3(10):767–777. https://doi.org/10.1016/S2213-8587(15)00227-2
doi: 10.1016/S2213-8587(15)00227-2 pubmed: 26165396
Simmons D, Devlieger R, van Assche A et al (2017) Effect of physical activity and/or healthy eating on GDM risk: the DALI lifestyle study. J Clin Endocrinol Metab 102(3):903–913. https://doi.org/10.1210/jc.2016-3455
doi: 10.1210/jc.2016-3455 pubmed: 27935767
Koivusalo SB, Rono K, Klemetti MM et al (2016) Gestational diabetes mellitus can be prevented by lifestyle intervention: the finnish gestational diabetes prevention study (RADIEL): a randomized controlled trial. Diabetes Care 39(1):24–30. https://doi.org/10.2337/dc15-0511
doi: 10.2337/dc15-0511 pubmed: 26223239
Dodd JM, Turnbull D, McPhee AJ et al (2014) Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. Bmj 348:g1285. https://doi.org/10.1136/bmj.g1285
doi: 10.1136/bmj.g1285 pubmed: 24513442 pmcid: 3919179
Song C, Li J, Leng J, Ma RC, Yang X (2016) Lifestyle intervention can reduce the risk of gestational diabetes: a meta-analysis of randomized controlled trials. Obes Rev 17(10):960–969. https://doi.org/10.1111/obr.12442
doi: 10.1111/obr.12442 pubmed: 27417680
Huvinen E, Eriksson JG, Stach-Lempinen B, Tiitinen A, Koivusalo SB (2018) Heterogeneity of gestational diabetes (GDM) and challenges in developing a GDM risk score. Acta Diabetol 55(12):1251–1259. https://doi.org/10.1007/s00592-018-1224-x
doi: 10.1007/s00592-018-1224-x pubmed: 30221319

Auteurs

Katrien Benhalima (K)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Louvain, Belgium. katrien.benhalima@uzleuven.be.

Paul Van Crombrugge (P)

Department of Endocrinology, OLV ziekenhuis Aalst-Asse-Ninove, Moorselbaan 164, 9300, Aalst, Belgium.

Carolien Moyson (C)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Louvain, Belgium.

Johan Verhaeghe (J)

Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Louvain, Belgium.

Sofie Vandeginste (S)

Department of Obstetrics and Gynecology, OLV ziekenhuis Aalst-Asse-Ninove, Moorselbaan 164, 9300, Aalst, Belgium.

Hilde Verlaenen (H)

Department of Obstetrics and Gynecology, OLV ziekenhuis Aalst-Asse-Ninove, Moorselbaan 164, 9300, Aalst, Belgium.

Chris Vercammen (C)

Department of Endocrinology, Imelda ziekenhuis, Imeldalaan 9, 2820, Bonheiden, Belgium.

Toon Maes (T)

Department of Endocrinology, Imelda ziekenhuis, Imeldalaan 9, 2820, Bonheiden, Belgium.

Els Dufraimont (E)

Department of Obstetrics and Gynecology, Imelda ziekenhuis, Imeldalaan 9, 2820, Bonheiden, Belgium.

Christophe De Block (C)

Department of Endocrinology-Diabetology-Metabolism, Antwerp University Hospital, Wilrijkstraat 10, 2560, Edegem, Belgium.

Yves Jacquemyn (Y)

Department of Obstetrics and Gynecology, Antwerp University Hospital, Wilrijkstraat 10, 2560, Edegem, Belgium.
ASTARC and Global Health Institute, Antwerp University, UA, Prinsstraat 13, 2000, Antwerp, Belgium.

Farah Mekahli (F)

Department of Endocrinology, Kliniek St-Jan Brussel, Kruidtuinlaan 32, 1000, Brussels, Belgium.

Katrien De Clippel (K)

Department of Obstetrics and Gynecology, Kliniek St-Jan Brussel, Kruidtuinlaan 32, 1000, Brussels, Belgium.

Annick Van Den Bruel (A)

Department of Endocrinology, AZ St Jan Brugge, Ruddershove 10, 8000, Brugge, Belgium.

Anne Loccufier (A)

Department of Obstetrics and Gynecology, AZ St Jan Brugge, Ruddershove 10, 8000, Brugge, Belgium.

Annouschka Laenen (A)

Center of Biostatics and Statistical Bioinformatics, KU Leuven, Kapucijnenvoer 35 bloc d - box 7001, 3000, Louvain, Belgium.

Caro Minschart (C)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Louvain, Belgium.

Roland Devlieger (R)

Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Louvain, Belgium.

Chantal Mathieu (C)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Herestraat 49, 3000, Louvain, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH